The problem of metabolic, cardiovascular, neurodegenerative, and
musculoskeletal diseases is incredibly significant these days due to their high
occurrence rate among people globally. Irisin is one of the myokines that has
become relevant for multiple physiological roles and has therapeutic potential in
different diseases. It increases thermogenesis and improves glucose metabolism
by converting white into beige fat tissue. Patients with obesity and type 2
diabetes demonstrate decreased levels of irisin, suggesting a connection to insulin
resistance and metabolic dysfunction. Irisin shows promising therapeutic
properties for diabetes complications due to its protective effects on vascular
endothelial cells and kidney function. Additionally, this myokine is vital in
neurological conditions, such as Alzheimer’s disease (AD), by reducing amyloid-
β accumulation, supporting synaptic plasticity, and limiting oxidative stress and
inflammation. In the cardiovascular system, irisin protects the heart muscle by
improving mitochondrial function, reducing infarct size, and regulating the
activity of the vagus nerve. Scientists proved that irisin is important for the
musculoskeletal system by stimulating muscle growth and regeneration,
preventing atrophy, and supporting bone remodeling via osteoblast activation
and osteoclast differentiation. In this review, we discuss the role of irisin as a
myokine with significant therapeutic potential in metabolic, neurodegenerative,
cardiovascular, and musculoskeletal disorders.
Keywords: irisin, type 2 diabetes, cardiovascular, neurodegenerative,
musculoskeletal
